Biohit strikes Dx supply deal with Hefei Medicine

05/17/2013 | GenomeWeb Daily News (free registration)

Biohit, a biotech company based in Finland, has tapped Hefei Medicine to distribute its diagnostic products in China for undisclosed terms. The deal covers products such as the GastroPanel system, a blood-based biomarker assay used to detect Helicobacter pylori.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI